The researchers took a “safety-first” approach. They deliberately excluded all viruses that infect humans or animals from the ...
This special edition gathers expert insight on cancer, addiction, sustainability and biotechnology, showing how ...
Researchers reckon it could dramatically accelerate understanding of how DNA influences disease, cancer, and drug discovery.
DeepMind’s AlphaGenome AI model could help solve the problem of predicting how variations in noncoding DNA shape gene ...
How do cutting-edge science and technology respond to ethical and legal issues when incorporated into society? These issues ...
Once disregarded as “junk DNA,” scientists now know that this molecular dark matter is crucial for determining gene activity ...
Michael Kalos, Ph.D., is the founder and managing director of Next Pillar Consulting, where he advises biopharmaceutical and venture organizations. He is also a Venture Partner with Alloy Therapeutics ...
The human brain's soft folds and ridges, arising in early development and continuing through the first 18 months of life, are ...
CRISPR–Cas9-based therapies are widely investigated for their clinical applications. However, there are limitations associated with the strategy, including off-target DNA editing. A group of ...
A research team led by the University of Oxford's Department of Engineering Science has shown it is possible to engineer a ...
South Korean pet-tech pioneer Jennerbio introduces Peter’s Lab, an AI-powered screening kit that predicts pet health risks using genetic analysis. Our mission is to turn love into science, ensuring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results